This examine presents the case of a Metropolitan Municipality in the Aegean Region of Turkey, which undertook a sequence of initiatives to conduct initiatives on environmental safety and sustainability. This case examine was carried out as two separate research as a component of Horizon 2020-funded ECHOES mission underneath Work Package 6, aiming to achieve perception into the collective magnitudes of energy-related selections and conduct. The place to begin of the course of is marked, in 2015, by the municipality turning into a celebration to the Covenant of Mayors motion, becoming a member of round 8,000 signatories from over 50 international locations.
In line with European Union’s (EU’s) local weather targets and related energy-related insurance policies, signatories of the Covenant of Mayors goal to lower carbon emissions by 20% by 2020 and by 40% by 2030. In order to reinforce the design and operationalization of insurance policies for attaining these targets, every accomplice in the Covenant of Mayors is required to develop a Sustainable Energy Action Plan (SEAP). The SEAP is to be ready inside 2 years of turning into a celebration to the Covenant of Mayors and entails motion plans and initiatives in order to operationalize the methods for attaining the related targets.
To this finish, this examine analyzes the Metropolitan Municipality’s SEAP and its parts, which embody zero-emission public transportation mission, transformation of present buildings to a extra energy-efficient commonplace and associated vitality audit research, a mission for lowering ready intervals in visitors through a Smart Traffic System, a pedestrianization mission, and a mission for rising the use of geothermal vitality for district heating.
This examine got down to determine the inner and exterior components, in addition to bottom-up and top-down mechanisms concerned in numerous phases of the preparation and implementation of the SEAP. The analysis methodology was knowledgeable interviews, incorporating viewpoints and perceptions of stakeholders from totally different ranges of the municipality. Among the key outcomes are understanding the roles of fanatics and frontrunners in such initiative and the significance of top-management and central authorities assist.
Seroprevalence and molecular detection of Leishmania spp. in cats of West Aegean Region, Turkey
Zoonotic visceral leishmaniasis is attributable to protozoa of the genus Leishmania. Although canines are thought-about to be major reservoir hosts of Leishmania spp., a number of mammals, corresponding to foxes, jackals and small rodents may be hosts of totally different Leishmania spp. Previously, cats have been thought-about as asymptomatic hosts of the parasite with out appearing as a reservoir. In latest years, there was an rising quantity of leishmaniasis circumstances in cats, particularly in areas the place the an infection endemically happens. This knowledge point out that cats usually tend to be one of the fundamental reservoirs of Leishmania spp. relatively than being a non-reservoir host.
The goal of this examine is to find out the prevalence of Leishmania spp. by molecular and serological methods amongst owned and stray cats in 4 totally different cities situated in western half of Turkey. A whole of 386 blood and 301 serum samples have been collected from cats in Western Turkey the place leishmaniasis is endemic. Feline serum samples have been examined by IFAT to detect IgG antibodies towards Leishmania spp. antigens. Blood samples collected from 386 cats have been examined by PCR for the presence of Leishmania spp. According to PCR outcomes utilizing RV1/RV2 primers, 9 (2.3%) out of 386 samples have been optimistic for Leishmania spp.
Further PCR evaluation utilizing MC1/MC2 primers confirmed that one cat in Izmir was discovered to be contaminated with L. infantum/donovani complicated. Sequence evaluation revealed the presence of L. infantum, L. main and L. tropica amongst sampled cats in western half of Turkey. On the different hand, IFAT outcomes indicated that an total of 47 out of 301 (15.6%) cats that examined by PCR have been discovered to have anti-Leishmania anti bodies. Also, six of the seropositive cats have been owned animals. The current examine demonstrated that each owned and stray cats will be contaminated with Leishmania spp. and could be potential reservoirs for different animals and people.
Therefore, all communities residing in or close by endemic areas ought to be made conscious of the function of cats as potential reservoirs of an infection. In endemic areas, all animals ought to be protected towards an infection with pesticides and monitored routinely to manage the unfold of zoonotic visceral leishmaniasis.
Effect of East Asian atmospheric particulate matter deposition on bacterial exercise and neighborhood construction in the oligotrophic Northwest Pacific
Large quantities of anthropogenic East Asian (EA) particulate issues (PM), containing inorganic vitamins and natural matter, are deposited in the oligotrophic Northwest Pacific Ocean. However, the results of such deposition on marine microbes stay unclear. In this examine, the impact of EA PM deposition on marine micro organism was assessed by 5 on-board microcosm experiments, carried out in oligotrophic basins of the South China Sea. The addition of EA PM to the sampling water induced a transparent shift in bacterial neighborhood composition from prevailing oligotrophs (i.e., SAR 11 clade, Prochlorococcus, AEGEAN-169 marine group) to much less widespread copiotrophs (i.e., Alteromonas, Ruegeria, Flavobacteriaceae) and thus a slight improve in bacterial range.
The shift to extra energetic neighborhood composition, in addition to stimulation of PM vitamins, resulted in a big improve in cell-specific and bulk bacterial manufacturing. In distinction, there have been solely minor modifications in bacterial abundance, presumably because of elevated top-down mortality. The EA PM additionally exhibited a stronge poisonous impact on pico-cyanobacteria, resulting in a big lower in their proportion. Moreover, the responses of bacterial metabolism and neighborhood composition exhibited vital relationships with the hydrographic situation of the areas.
Human Protein SOX- 15, SOX15 ELISA KIT |
|||
| ELI-18231h | Lifescience Market | 96 Tests | 824 EUR |
9998 SCREW CAP 415/15 |
|||
| 9998-15 | CORNING | 288/pk | 198 EUR |
|
Description: General Apparatus; Stoppers |
|||
IL-15 Interleukin-15 Mouse Recombinant Protein |
|||
| PROTP48346 | BosterBio | Regular: 10ug | 317 EUR |
|
Description: Interleukin-15 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 115 amino acids and having a molecular mass of 13321 Dalton. ;The IL-15 is purified by proprietary chromatographic techniques. |
|||
DiagNano Fluorophore Labeled Gold Nanoparticles, 15 nm |
|||
| GFL-15 | Creative Diagnostics | 1 mL | 1053 EUR |
AXYGEN® HORIZONTAL GEL BOX, 15 CM |
|||
| HGB-15 | CORNING | 1/pk | 486 EUR |
|
Description: Lab Equipment; Axygen Branded EQ |
|||
AXYGEN® GEL TRAY 15 X 15 CM FOR USE WITH 15 CM GEL BOX, UV TRANSPARENT |
|||
| HGB15-15-GT | CORNING | 1/pk | 79 EUR |
|
Description: Lab Equipment; Axygen Branded EQ |
|||
DiagNano Gold Nanoparticle Passive Conjugation Kit, 15 nm |
|||
| GPK-15 | Creative Diagnostics | 1 kit | 715 EUR |
IL-15 Interleukin-15 Mouse Recombinant Protein, His Tag |
|||
| PROTP48346-1 | BosterBio | Regular: 10ug | 317 EUR |
|
Description: Interleukin-15 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 152 amino acids (49-162 a.a.) and having a molecular mass of 17.6 kDa. ;The IL-15 is fused to a 37 amino acid His Tag at N-terminus and purified by proprietary chromatographic techniques. |
|||
FGF-15 Fibroblast Growth Factor-15 Mouse Recombinant Protein |
|||
| PROTO35622 | BosterBio | Regular: 10ug | 317 EUR |
|
Description: FGF-15 Protein is 23.78 kDa protein containing 203 amino acid residues including a 10 a.a. N-Terminal His-tag. |
|||
Recombinant Mouse Interleukin-15 |
|||
| 7-00973 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Interleukin-15 |
|||
| 7-00974 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Interleukin-15 |
|||
| 7-00975 | CHI Scientific | 1mg | Ask for price |
Sarcosine oxidase (20 U/mg material) |
|||
| SOX-01 | Alpha Diagnostics | 20 KU | 590 EUR |
IL-15 Interleukin-15 Human Recombinant Protein |
|||
| PROTP40933 | BosterBio | Regular: 10ug | 317 EUR |
|
Description: Interleukin-15 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 114 amino acids (and an N-terminal Methionine) and having a molecular mass of 12.8kDa. The IL-15 is purified by proprietary chromatographic techniques. |
|||
IL-15 Interleukin-15 Rat Recombinant Protein |
|||
| PROTP97604 | BosterBio | Regular: 10ug | 317 EUR |
|
Description: Interleukin-15 Rat Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 115 amino acids and having a molecular mass of 13533 Dalton. ;The IL-15 is purified by proprietary chromatographic techniques. |
|||
IL-15 Recombinant Protein |
|||
| 11-331 | ProSci | 0.05 mg | 595.25 EUR |
|
Description: Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health. |
|||
IL-15 Recombinant Protein |
|||
| 11-386 | ProSci | 0.05 mg | 710.75 EUR |
|
Description: Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells; cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health. |
|||
IL-15 Recombinant Protein |
|||
| 40-558 | ProSci | 0.01 mg | 401 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activities primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
| 40-260-0002mg | ProSci | 0.002 mg | 259.25 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 114 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
| 40-260-001mg | ProSci | 0.01 mg | 364.25 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 114 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
| 40-422-0002mg | ProSci | 0.002 mg | 259.25 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant murine IL-15 is a 13.3 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
| 40-422-001mg | ProSci | 0.01 mg | 364.25 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant murine IL-15 is a 13.3 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
| 40-476-0002mg | ProSci | 0.002 mg | 259.25 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant rat IL-15 is a 13.5 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
| 40-476-001mg | ProSci | 0.01 mg | 364.25 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant rat IL-15 is a 13.5 kDa protein consisting of 115 amino acid residues. |
|||
IL-15 Recombinant Protein |
|||
| 91-013 | ProSci | 0.05 mg | 684.5 EUR |
|
Description: Human Interleukin 15 (IL-15) is a cytokine that regulates T cell and natural killer cell activation and proliferation. IL-15 binds to the alpha subunit of the IL15 receptor (IL-15RA) with high affinity. IL-15 also binds to the beta and gamma chains of the IL-2 receptor, but not the alpha subunit of the IL2 receptor. IL-15 is structurally and functionally related to IL-2. Both cytokines share some subunits of receptors, allowing them to compete for and negatively regulate each other's activity. The number of CD8+ memory T cells is controlled by a balance between IL-15 and IL-2. Despite their many overlapping functional properties, IL-2 and IL-15 are, in fact, quite distinct players in the immune system. IL-15 is constitutively expressed by a wide variety of cell types and tissues, including monocytes, macrophages and DCs. Mature Human IL-15 shares 70% amino acid sequence identity with Mouse and Rat IL-15. |
|||
15-PGDH Recombinant Protein |
|||
| 91-661 | ProSci | 0.05 mg | 710.75 EUR |
|
Description: 15-hydroxyprostaglandin dehydrogenase [NAD(+)], also known as Prostaglandin dehydrogenase 1, 15-PGDH, HPGD and PGDH1, belongs to the short-chain dehydrogenases/reductases (SDR) family. HPGD localizes to the cytoplasm and can be found in colon epithelium, existing as a homodimer. HPGD catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. HPGD is down-regulated by cortisol, dexamethasone and betamethasone, up-regulated by TGFB1. HPGD inhibits in vivo proliferation of colon cancer cells. HPGD is the key enzyme for the inactivation of prostaglandins, and thus regulates processes such as inflammation or proliferation. |
|||
Mucin-15 Recombinant Protein |
|||
| 91-727 | ProSci | 0.05 mg | 684.5 EUR |
|
Description: Mucin-15 is a single-pass type I membrane protein member of the Mucin family. Mucins are a family of high molecular weight, heavily glycosylated proteins (glycoconjugates) produced by epithelial tissues in most metazoans. A key characteristic of Mucins is their ability to form gels. Therefore they are a key component in most gel-like secretions, serving functions from lubrication to cell signalling to forming chemical barriers. Mucin-15 is expressed in many tissues. Mucin-15 is highly glycosylated (N- and O-linked carbohydrates). Mucin-15 may play a role in the cell adhesion to the extracellular matrix. |
|||
SOX-10 |
|||
| MO47006 | Neuromics | 100 ug | 349 EUR |
DiagNano Fluorophore Labeled Gold Nanoparticles, 15 nm, Cellular Uptake |
|||
| GFL-15-CU | Creative Diagnostics | 1mL | 1365 EUR |
DiagNano Gold Nanoparticle Medium Covalent Conjugation Kit, 15 nm |
|||
| GCK-M-15 | Creative Diagnostics | 1 kit | 757 EUR |
Mouse Protein SOX- 16, Sox16 ELISA KIT |
|||
| ELI-52278m | Lifescience Market | 96 Tests | 865 EUR |
Mouse Protein SOX- 19, Sox19 ELISA KIT |
|||
| ELI-41411m | Lifescience Market | 96 Tests | 865 EUR |
Recombinant Human Interleukin-15/IL-15 |
|||
| C016-10ug | Novoprotein | 10ug | 202 EUR |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.0. |
|||
Recombinant Human Interleukin-15/IL-15 |
|||
| C016-1mg | Novoprotein | 1mg | 1836 EUR |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.0. |
|||
Recombinant Human Interleukin-15/IL-15 |
|||
| C016-500ug | Novoprotein | 500ug | 1298 EUR |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.0. |
|||
Recombinant Human Interleukin-15/IL-15 |
|||
| C016-50ug | Novoprotein | 50ug | 496 EUR |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.0. |
|||
Recombinant human Transcription factor SOX-10 |
|||
| P1489 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Transcription factor SOX-10 |
|||
Recombinant human Transcription factor SOX-7 |
|||
| P1745 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Transcription factor SOX-7 |
|||
Recombinant human Transcription factor SOX-13 |
|||
| P1789 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Transcription factor SOX-13 |
|||
Recombinant human Transcription factor SOX-12 |
|||
| P2617 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Transcription factor SOX-12 |
|||
Recombinant human Transcription factor SOX-21 |
|||
| P2827 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Transcription factor SOX-21 |
|||
IL-15 R alpha & IL-15 fusion protein Recombinant Protein |
|||
| 92-588 | ProSci | 0.05 mg | 542.75 EUR |
|
Description: Interleukin-15 receptor subunit alpha, also known as Il15ra, is a high-affinity receptor for interleukin-15. Il15ra associates as a heterotrimer with the IL-2 receptor beta and gamma subunits (Common gamma chain, or gamma c) to initiate signal transduction. It can signal both in cis and trans where IL15R from one subset of cells presents IL15 to neighboring IL2RG-expressing cells. Il15ra is expressed in special cells including a wide variety of Tand B cells and non-lymphoid cells. Human Il15ra shares 45% amino acid sequence homology with the mouse form of the receptor. Eight isoforms of IL-15 R alpha mRNA have been identified, resulting from alternative splicing events involving different exons.Interleukin 15 (IL-15) is a cytokine that regulates T cell and natural killer cell activation and proliferation. IL-15 binds to the alpha subunit of the IL15 receptor (IL-15RA) with high affinity. IL-15 also binds to the beta and gamma chains of the IL-2 receptor, but not the alpha subunit of the IL2 receptor. IL-15 is structurally and functionally related to IL-2. Both cytokines share some subunits of receptors, allowing them to compete for and negatively regulate each other's activity. The number of CD8+ memory T cells is controlled by a balance between IL-15 and IL-2. Despite their many overlapping functional properties, IL-2 and IL-15 are, in fact, quite distinct players in the immune system. IL-15 is constitutively expressed by a wide variety of cell types and tissues, including monocytes, macrophages and DCs. |
|||
Recombinant Human IL-15 Protein |
|||
| PROTP40933-3 | BosterBio | 10ug | 317 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowel disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 114 amino acid residues. |
|||
Recombinant Murine IL-15 Protein |
|||
| PROTP48346-2 | BosterBio | 10ug | 317 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant murine IL-15 is a 13.3 kDa protein consisting of 115 amino acid residues. |
|||
Recombinant Rat IL-15 Protein |
|||
| PROTP97604-1 | BosterBio | 10ug | 317 EUR |
|
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowl disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant rat IL-15 is a 13.5 kDa protein consisting of 115 amino acid residues. |
|||
Recombinant Human IL-15 Protein |
|||
| RP00393 | Abclonal | 10 μg | 221 EUR |
Recombinant human IL-15 Protein |
|||
| RP01236 | Abclonal | 10 μg | 193 EUR |
Bovine IL-15 Recombinant Protein |
|||
| R00212 | BosterBio | 5ug/vial | 259 EUR |
|
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Bovine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast. |
|||
Equine IL-15 Recombinant Protein |
|||
| R00212-1 | BosterBio | 5ug/vial | 259 EUR |
|
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Equine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast. |
|||
Swine IL-15 Recombinant Protein |
|||
| R00212-3 | BosterBio | 5ug/vial | 259 EUR |
|
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Swine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast. |
|||
Recombinant HPV-15 E1 Protein |
|||
| VAng-Wyb3028-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 15 Replication protein E1, recombinant protein. |
|||
Recombinant HPV-15 L2 Protein |
|||
| VAng-Wyb3032-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 15 Minor capsid protein L2, recombinant protein. |
|||
IL-15, human recombinant protein |
|||
| P1029-.01 | ApexBio | 10 µg | 300 EUR |
|
Description: Interleukin 15 (IL-15) is an immunomodulating cytokine mainly produced by adherent peripheral blood mononuclear cells, fibroblasts and epithelial cells and stimulates the proliferation of T lymphocytes. |
|||
IL-15, human recombinant protein |
|||
| P1029-.05 | ApexBio | 50 µg | 877 EUR |
|
Description: Interleukin 15 (IL-15) is an immunomodulating cytokine mainly produced by adherent peripheral blood mononuclear cells, fibroblasts and epithelial cells and stimulates the proliferation of T lymphocytes. |
|||
IL-15, human recombinant protein |
|||
| P1029-1 | ApexBio | 1 mg | 5339 EUR |
|
Description: Interleukin 15 (IL-15) is an immunomodulating cytokine mainly produced by adherent peripheral blood mononuclear cells, fibroblasts and epithelial cells and stimulates the proliferation of T lymphocytes. |
|||
IGHV3OR16-15 Recombinant Protein (Human) |
|||
| RP064674 | ABM | 100 ug | Ask for price |
IL-15 mutant Recombinant Protein |
|||
| 90-504 | ProSci | 50 ug | 595.25 EUR |
|
Description: Interleukin-15 (IL-15) has a broad spectrum of biological activities. It is crucial for the development, proliferation, survival and differentiation of multiple cells from both innate and adaptive immune systems. IL-15 up-regulation has a central role in the development of several autoimmune or chronic inflammatory disorders. Targeting IL-15 or its receptor may have a valuable impact on the treatment of immune-mediated diseases. IL-15 participates in the development of important immune antitumor mechanisms. It activates CD8(+) T cells, natural killer (NK) cells, NK T cells, and can promote the formation of antitumor antibodies. IL-15 can also protect T effector cells from the action of T regulatory cells and reverse tolerance to tumor-associated antigens. In pre-clinical studies IL-15 has been found to demonstrate potentiated antitumor effects following pre-association with IL-15Ralpha, or when used in combination with chemotherapy, adoptive therapy, monoclonal antibodies, and tumor vaccines. |
|||
Kallikrein-15 (Recombinant) |
|||
| 20-abx073427 | Abbexa |
|
|
IL-15 Interleukin-15 Human Recombinant Protein, His Tag |
|||
| PROTP40933-1 | BosterBio | Regular: 10ug | 317 EUR |
|
Description: Interleukin-15 His Human Recombinant ?produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 123 amino acids fragment (49-162) having a total molecular weight of 13.9 kDa with an C-terminal hexahistidine tag. _x000D_ The IL-15 His is purified by proprietary chromatographic techniques. _x000D_ _x000D_ |
|||
HPGD Hydroxyprostaglandin Dehydrogenase 15-(NAD) Mouse Recombinant Protein |
|||
| PROTQ8VCC1 | BosterBio | Regular: 20ug | 317 EUR |
|
Description: HPGD Mouse Recombinant produced in E. coli is a single polypeptide chain containing 292 amino acids (1-269) and having a molecular mass of 31.6kDa. ;HPGD is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant Mouse IL-15 Protein, Untagged, E.coli-100ug |
|||
| QP5406-100ug | EnQuireBio | 100ug | 545 EUR |
Recombinant Mouse IL-15 Protein, Untagged, E.coli-10ug |
|||
| QP5406-10ug | EnQuireBio | 10ug | 237 EUR |
Recombinant Mouse IL-15 Protein, Untagged, E.coli-1mg |
|||
| QP5406-1mg | EnQuireBio | 1mg | 3754 EUR |
Recombinant Mouse IL-15 Protein, Untagged, E.coli-2ug |
|||
| QP5406-2ug | EnQuireBio | 2ug | 136 EUR |
Recombinant Mouse IL-15 Protein, Untagged, E.coli-500ug |
|||
| QP5406-500ug | EnQuireBio | 500ug | 2322 EUR |
Recombinant Mouse Fibroblast Growth Factor-15 |
|||
| 7-00370 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Fibroblast Growth Factor-15 |
|||
| 7-00371 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Fibroblast Growth Factor-15 |
|||
| 7-00372 | CHI Scientific | 1mg | Ask for price |
Recombinant Mouse Interleukin-15, His Tag |
|||
| 7-00976 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Interleukin-15, His Tag |
|||
| 7-00977 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Interleukin-15, His Tag |
|||
| 7-00978 | CHI Scientific | 1mg | Ask for price |
Human CellExp? Siglec-15, Mouse Recombinant |
|||
| P1466-10 | Biovision | 164 EUR | |
Human CellExp? Siglec-15, Mouse Recombinant |
|||
| P1466-50 | Biovision | 479 EUR | |
TruStrip Sample Transfer Strips, 15-ul, 50/Pk (without sample tracking dye) |
|||
| STS-15-50 | Alpha Diagnostics | 1 Pk | Ask for price |
TruStrip Sample Transfer Strips, 15-ul, 50/Pk (with sample tracking dye) |
|||
| STSD-15-50 | Alpha Diagnostics | 1 Pk | Ask for price |
LIGHT, Human Recombinant |
|||
| P1291-15 | Biovision | 370 EUR | |
Sox-11 Antibody |
|||
| 45394-100ul | SAB | 100ul | 252 EUR |
Sox-11 Antibody |
|||
| 45394-50ul | SAB | 50ul | 187 EUR |
SOX 10 Antibody |
|||
| P1005-01m | SAB | 0.1m | 231 EUR |
SOX 10 Antibody |
|||
| P1005-1ml | SAB | 1ml | 803 EUR |
Sox- 11 Antibody |
|||
| ABD8614 | Lifescience Market | 100 ug | 438 EUR |
Sox-11 Antibody |
|||
| DF8614 | Affbiotech | 200ul | 304 EUR |
|
Description: Sox-11 Antibody detects endogenous levels of total Sox-11. |
|||
Sox-1 Antibody |
|||
| 3822-100 | Biovision | 316 EUR | |
Sox-1 Antibody |
|||
| 3822-30T | Biovision | 146 EUR | |
Sox-2 Antibody |
|||
| 3889-100 | Biovision | 316 EUR | |
Sox-2 Antibody |
|||
| 3889-30T | Biovision | 146 EUR | |
Sox 1 antibody |
|||
| 20R-1736 | Fitzgerald | 100 ug | 673 EUR |
|
Description: Rabbit polyclonal Sox 1 antibody |
|||
Mouse Interleukin-15 (IL-15) Antibody |
|||
| 32200-05111 | AssayPro | 150 ug | 261 EUR |
Mouse Bone Morphogenetic Protein 15(BMP-15)Elisa kit |
|||
| CSB-E14365m-24T | Cusabio | 1 plate of 24 wells | 165 EUR |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse Bone Morphogenetic Protein 15 (BMP-15) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Mouse Bone Morphogenetic Protein 15(BMP-15)Elisa kit |
|||
| 1-CSB-E14365m | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse Bone Morphogenetic Protein 15(BMP-15) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
sIL-4R?, Human Recombinant |
|||
| P1287-15 | Biovision | 370 EUR | |
Mouse Protocadherin 15 (PCDH15) Protein |
|||
| 20-abx650579 | Abbexa |
|
|
Mouse Interleukin 15 (IL15) Protein |
|||
| abx670290-10ug | Abbexa | 10 ug | 551 EUR |
Mouse Interleukin 15 (IL15) Protein |
|||
| 20-abx067449 | Abbexa |
|
|
Mouse Interleukin 15 (IL15) Protein |
|||
| 20-abx261822 | Abbexa |
|
|
Mouse Interleukin 15 (IL15) Protein |
|||
| 20-abx262266 | Abbexa |
|
|
Recombinant Bone Morphogenetic Protein 15 (BMP15) |
|||
| 4-RPC107Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Bone Morphogenetic Protein 15 expressed in: E.coli |
|||
Recombinant Bone Morphogenetic Protein 15 (BMP15) |
|||
| 4-RPC107Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Bone Morphogenetic Protein 15 expressed in: E.coli |
|||
Stronger promotion results of the EA PM on bacterial manufacturing and neighborhood shift from oligotrophs to copiotrophs was demonstrated at the extra oligotrophic websites with decrease chlorophyll a concentrations. These outcomes recommend that PM deposition from polluted areas has the potential to change the typical oligotrophic microbiomes and alter the web metabolic steadiness of the bacterial neighborhood. These will then affect the dynamics of carbon circulate in microbial meals webs and biogeochemical cycles, particularly with the pattern of world warming and enlargement of low-chlorophyll areas.